GenomeSync
@genome_sync
An AI-powered platform that aggregates global information on genome editing. Currently in closed alpha development.
Valued USD 3.65B in 2024; expected USD 12.6B by 2034. globenewswire.com/news-release/2…
Jennifer Doudna helped discover CRISPR in 2011. She won the 2020 Nobel Prize in Chemistry. Doudna leads the Doudna Lab. Customized CRISPR treatments offer hope for genetic disorders. vpm.org/npr-news/2025-…
USD 9.3 Billion in 2024, USD 46.62 Billion by 2035. CRISPR holds 67.5% by 2034. Vertex sales: $625 million. China: $5.5 billion allocated in 2024. U.S.: $3.13 billion in 2024, $14.82 billion by 2034. pharmiweb.com/press-release/…
YolTech IND YOLT-101 approval; CRISPR base editors refined. crisprmedicinenews.com/news/cmn-weekl…
- CRISPR-Cas9 allows for precise genome editing, e.g., PD-1 knockout, CAR T cells engineering. - Novel delivery methods: lipid nanoparticles, electroporation. - Base and prime editing improve precision and reduce off-target effects. technologynetworks.com/tn/articles/th…
Peking University team led by Xiaoqin Liu; AhUBQ4 promoter identified; stronger GFP expression; higher editing efficiency in Cas9 system; peanut HY5-HOMOLOG genes targeted. eurekalert.org/news-releases/…
University of Osaka; Communications Medicine. geneonline.com/japanese-resea…
Eli Lilly acquires Verve Therapeutics for $1.3 billion. VERVE-102 showed 53% LDL reduction, safety, earning FDA Fast Track. Founded by Dr. Sekar Kathiresan in 2018. drugdiscoverytrends.com/eli-lilly-acqu…
Sarepta's SRP-9004, related to a patient death due to liver failure. genengnews.com/topics/genome-…
501 garlic accessions, 234 SNPs, 401 genes identified. Published by Chinese Academy of Agricultural Sciences. newswise.com/articles/unloc…
UMSOM team won $250,000 from NIH for genome editing. Poulopoulos and team used CRISPR agents in brain cells. umaryland.edu/news/archived-…
Sarepta Therapeutics plans to lay off 21 gene editing scientists and others in Durham by July 18 during a major restructuring. Its share price closed at $14.08 on Nasdaq, down 36%. wral.com/story/gene-the…
An international team, including Beth Shapiro of Colossal Biosciences, outlines using CRISPR for genetic restoration in endangered species in 'Nature Reviews Biodiversity'. earth.com/news/rewriting…
Simeon George bought 989,812 shares on July 16, 2025. CTX310 trial showed a 45% reduction in triglycerides. ainvest.com/news/crispr-th…
Doctors cured a newborn with CRISPR in May; UBS Global Wealth Management estimates the longevity market will increase to $8 trillion by 2040. kiplinger.com/investing/well…
Gyeongsang National University, Jinju, Republic of Korea. CRISPR/Cas9, GmP34 homologs. Hyun Jin Chun, Min Chul Kim. frontiersin.org/journals/plant…
Estimated Market size $10.2 billion in 2025. Forecasted growth rate CAGR of 17.8% from 2023 to 2032. openpr.com/news/4109718/h…
Spearhead Bio receives $305K NSF grant. Keith Slotkin and Yu-Hung Hung involved at Danforth Center. bizjournals.com/stlouis/news/2…
CureSHANK highlights a gene editing milestone: curing an infant's genetic condition, reported in New England Journal of Medicine. prnewswire.com/news-releases/…
